8086 Stock Overview
Engages in the medical devices, pharmaceuticals, and pharma packaging businesses.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Nipro Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,215.50 |
| 52 Week High | JP¥1,302.50 |
| 52 Week Low | JP¥1,000.50 |
| Beta | 0.11 |
| 1 Month Change | -3.38% |
| 3 Month Change | -1.10% |
| 1 Year Change | 19.05% |
| 3 Year Change | -9.09% |
| 5 Year Change | 2.06% |
| Change since IPO | 102.86% |
Recent News & Updates
Shareholder Returns
| 8086 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 3.0% | 1.3% | 1.0% |
| 1Y | 19.1% | 6.4% | 24.0% |
Return vs Industry: 8086 exceeded the JP Medical Equipment industry which returned 6% over the past year.
Return vs Market: 8086 underperformed the JP Market which returned 23.9% over the past year.
Price Volatility
| 8086 volatility | |
|---|---|
| 8086 Average Weekly Movement | 3.2% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 7.8% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 8086 has not had significant price volatility in the past 3 months.
Volatility Over Time: 8086's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 38,770 | Yoshihiko Sano | www.nipro.co.jp |
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. The company’s Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services.
Nipro Corporation Fundamentals Summary
| 8086 fundamental statistics | |
|---|---|
| Market cap | JP¥198.24b |
| Earnings (TTM) | JP¥11.11b |
| Revenue (TTM) | JP¥586.79b |
17.8x
P/E Ratio0.3x
P/S RatioIs 8086 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8086 income statement (TTM) | |
|---|---|
| Revenue | JP¥586.79b |
| Cost of Revenue | JP¥415.47b |
| Gross Profit | JP¥171.32b |
| Other Expenses | JP¥160.21b |
| Earnings | JP¥11.11b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 68.11 |
| Gross Margin | 29.20% |
| Net Profit Margin | 1.89% |
| Debt/Equity Ratio | 224.5% |
How did 8086 perform over the long term?
See historical performance and comparison